F. Zhao, T. Lin, W. He, J. Han, D. Zhu, K. Hu et al., Knockdown of a novel lincRNA AATBC suppresses proliferation and induces apoptosis in bladder cancer. Oncotarget 6(2), 1064–1078 (2015). https://doi.org/10.18632/oncotarget.2833
J. Zhuang, Q. Lu, B. Shen, X. Huang, L. Shen, X. Zheng et al., TGFbeta1 secreted by cancer-associated fibroblasts induces epithelial-mesenchymal transition of bladder cancer cells through lncRNA-ZEB2NAT. Sci. Rep. 5, 11924 (2015). https://doi.org/10.1038/srep11924
Article PubMed PubMed Central Google Scholar
D.P. Bartel, MicroRNAs: Target recognition and regulatory functions. Cell 136(2), 215–233 (2009). https://doi.org/10.1016/j.cell.2009.01.002
Article CAS PubMed PubMed Central Google Scholar
G. Hutvágner, P.D. Zamore, A microRNA in a multiple-turnover RNAi enzyme complex. Science 297(5589), 2056–2060 (2002). https://doi.org/10.1126/science.1073827
Article CAS PubMed Google Scholar
R. Gary, Clarifications on miRNA and Cancer. Science 311(5757), 36–37 (2006). https://doi.org/10.1126/science.311.5757.36d
L. Poliseno, L. Salmena, J. Zhang, B. Carver, W.J. Haveman, P.P. Pandolfi, A coding independent function of gene and pseudogene mRNAs regulates tumour biology. Nature 465(7301), 1033–1038 (2010). https://doi.org/10.1038/nature09144
Article CAS PubMed PubMed Central Google Scholar
Y. Tay, L. Kats, L. Salmena, D. Weiss, S.M. Tan, U. Ala, F. Karreth, L. Poliseno, P. Provero, F. Di Cunto, J. Lieberman, I. Rigoutsos, P.P. Pandolfi, Coding-independent regulation of the tumor suppressor PTEN by competing endogenous mRNAs. Cell 147(2), 344–357 (2011). https://doi.org/10.1016/j.cell.2011.09.029
Article CAS PubMed PubMed Central Google Scholar
L. Salmena, L. Poliseno, Y. Tay, L. Kats, P.P. Pandolfi, A ceRNA hypothesis: The Rosetta stone of a hidden RNA language? Cell 146(3), 353–358 (2011). https://doi.org/10.1016/j.cell.2011.07.014
Article CAS PubMed PubMed Central Google Scholar
J. Jeffery, D. Sinha, S. Srihari, M. Kalimutho, K.K. Khanna, Beyond cytokinesis: The emerging roles of CEP55 in tumorigenesis. Oncogene 35(6), 683–690 (2016). https://doi.org/10.1038/onc.2015.128
Article CAS PubMed Google Scholar
M. Sakai, T. Shimokawa, T. Kobayashi, S. Matsushima, Y. Yamada, Y. Nakamura, Y. Furukawa, Elevated expression of C10orf3 (chromosome 10 open reading frame 3) is involved in the growth of human colon tumor. Oncogene 25(3), 480–486 (2006). https://doi.org/10.1038/sj.onc.1209051
Article CAS PubMed Google Scholar
Z.C. Weijing, N. Weiling, H. Teng, H. Xiaoying, X. Sun Liqun, Z. Yanna, Upregulation of centrosomal protein 55 is associated with unfavorable prognosis and tumor invasion in epithelial ovarian carcinoma. Tumor Biol. 37(5), 6239–6254 (2016). https://doi.org/10.1007/s13277-015-4419-6
W. Zhang, C. Niu, W. He, T. Hou, X. Sun, L. Xu, Z. Yanna, Upregulation of centrosomal protein 55 is associated with unfavorable prognosis and tumor invasion in epithelial ovarian carcinoma. Tumor Biol. 37(5), 6239–6254 (2016). https://doi.org/10.1007/s13277-015-4419-6
T. Shiraishi, N. Terada, Y. Zeng, T. Suyama, J. Luo, B. Trock, P. Kulkarni, R.H. Getzenberg, Cancer/testis antigens as potential predictors of biochemical recurrence of prostate cancer following radical prostatectomy. J. Transl. Med. 9(1), 153 (2011). https://doi.org/10.1186/1479-5876-9-153
Article PubMed PubMed Central Google Scholar
C.-H. Chen, P.-J. Lu, Y.-C. Chen, S.-L. Fu, K.-J. Wu, A.-P. Tsou, Y.-C.G. Lee, T.-C.E. Lin, S.-L. Hsu, W.-J. Lin, C.-Y.F. Huang, C.-K. Chou, FLJ10540-elicited cell transformation is through the activation of PI3-kinase/AKT pathway. Oncogene 26(29), 4272–4283 (2007). https://doi.org/10.1038/sj.onc.1210207
Article CAS PubMed Google Scholar
P.K. Singh, A.K. Srivastava, S.K. Rath, D. Dalela, M.M. Goel, M.L.B. Bhatt, Expression and clinical significance of Centrosomal protein 55 (CEP55) in human urinary bladder transitional cell carcinoma. Immunobiology 220(1), 103–108 (2015). https://doi.org/10.1016/j.imbio.2014.08.014
Article CAS PubMed Google Scholar
Joseph A., DiDonato Frank, Mercurio Michael, Karin, NF-κB and the link between inflammation and cancer. Immunol. Rev. 246(1), 379–400 (2012). https://doi.org/10.1111/j.1600-065X.2012.01099.x
K. Motoyama, H. Inoue, Y. Nakamura, H. Uetake, K. Sugihara, M. Mori, Clin. Cancer Res. 14(8), 2334–2340 (2008). https://doi.org/10.1158/1078-0432.CCR-07-4667
Article CAS PubMed Google Scholar
H. He, R. Chang, T. Zhang, C. Yang, Z. Kong, ATM mediates DAB2IP-deficient bladder cancer cell resistance to ionizing radiation through the p38MAPK and NF-κB signaling pathway. Mol. Med. Rep. 16(2), 1216–1222 (2017). https://doi.org/10.3892/mmr.2017.6689
Article CAS PubMed PubMed Central Google Scholar
A. Slusser-Nore, S.H. Garrett, X.D. Zhou, D.A. Sens, M.A. Sens, S. Somji, The expression of keratin 6 is regulated by the activation of the ERK1/2 pathway in arsenite transformed human urothelial cells. Toxicol. Appl. Pharmacol, 33141–33153 (2017). https://doi.org/10.1016/j.taap.2017.05.007
D. Lv, H. Wu, R. Xing, F. Shu, B. Lei, C. Lei, X. Zhou, B. Wan, Y. Yang, L. Zhong, X. Mao, Y. Zou, HnRNP-L mediates bladder cancer progression by inhibiting apoptotic signaling and enhancing MAPK signaling pathways. Oncotarget. 8(8), 13586–13599 (2017). https://doi.org/10.18632/oncotarget.14600
Article PubMed PubMed Central Google Scholar
S.Q. Xin, D. Zhaofeng, L. Zhiqi, L. Hao, G. Li, Z. Qirui, Z. Jie, L. Jiaxing, M. Daming, Y. Wang Dexin, Z. Caiyun, Cigarette smoke extract induces epithelial–mesenchymal transition of human bladder cancer T24 cells through activation of ERK1/2 pathway. Biomed. Pharmacother. 86, 457-465 (2017). https://doi.org/10.1016/j.biopha.2016.12.022
F. Calabrò, V. Lorusso, G. Rosati, L. Manzione, L. Frassineti, T. Sava, E.D. Di Paula, S. Alonso, C.N. Sternberg, Gemcitabine and paclitaxel every 2 weeks in patients with previously untreated urothelial carcinoma. Cancer 115(12), 2652–2659 (2009). https://doi.org/10.1002/cncr.24313
Article CAS PubMed Google Scholar
J. Xu, Y. Li, J. Lu, T. Pan, N. Ding, Z. Wang, T. Shao, J. Zhang, L. Wang, X. Li, The mRNA related ceRNA–ceRNA landscape and significance across 20 major cancer types. Nucleic Acids Res. 43(17), 8169–8182 (2015). https://doi.org/10.1093/nar/gkv853
Article CAS PubMed PubMed Central Google Scholar
S. Ergun, S. Oztuzcu, Oncocers: ceRNA-mediated cross-talk by sponging miRNAs in oncogenic pathways. Tumor Biol. 36(5), 3129–3136 (2015). https://doi.org/10.1007/s13277-015-3346-x
H.-S. Chiu, M.R. Martínez, M. Bansal, A. Subramanian, T.R. Golub, X. Yang, P. Sumazin, A. Califano, High-throughput validation of ceRNA regulatory networks. BMC Genomics 18(1), 418 (2017). https://doi.org/10.1186/s12864-017-3790-7
Article CAS PubMed PubMed Central Google Scholar
M.S. Kumar, E. Armenteros-Monterroso, P. East, P. Chakravorty, N. Matthews, M.M. Winslow, J. Downward, HMGA2 functions as a competing endogenous RNA to promote lung cancer progression. Nature 505(7482), 212–217 (2014). https://doi.org/10.1038/nature12785
Article CAS PubMed Google Scholar
G. Wang, M. Liu, H. Wang, S. Yu, Z. Jiang, J. Sun, K. Han, J. Shen, M. Zhu, Z. Lin, C. Jiang, M. Guo, Centrosomal protein of 55 regulates glucose metabolism proliferation and apoptosis of glioma cells via the Akt/mTOR signaling pathway. J. Cancer 7(11), 1431–1440. https://doi.org/10.7150/jca.15497
T. Zheng, J. Chou, F. Zhang, Y. Liu, H. Ni, X. Li, L. Zheng, T. Tang, L. Jin, T. Xi, CXCR4 3′UTR functions as a ceRNA in promoting metastasis proliferation and survival of MCF-7 cells by regulating miR-146a activity. Eur. J. Cell Biol. 94(10), 458–469 (2015). https://doi.org/10.1016/j.ejcb.2015.05.010
Article CAS PubMed Google Scholar
S. Lamouille, J. Xu, R. Derynck, Molecular mechanisms of epithelial–mesenchymal transition. Nat. Rev. Mol. Cell Biol. 15(3), 178–196 (2014). https://doi.org/10.1038/nrm3758
Article CAS PubMed PubMed Central Google Scholar
M.A. Nieto, Epithelial plasticity: A common theme in embryonic and cancer cells. Science 342(6159), 1234850 (2013). https://doi.org/10.1126/science.1234850
Article CAS PubMed Google Scholar
Laurie K, McCauley T John, Martin, Twenty-five years of PTHrP progress: From cancer hormone to multifunctional cytokine. J. Bone Miner. Res. 27(6), 1231–1239 (2012). https://doi.org/10.1002/jbmr.1617
G. Manfioletti, V. Giancotti, A. Bandiera, E. Buratti, P. Sautièere, P. Cary, C. Crane-Robinson, B. Coles, G.H. Goodwin, cDNA cloning of the HML-C phosphoprotein a nclear protein associated with neoplastic and undifferentiated phenotypes. Nucleic Acids Res. 19(24), 6793–6797 (1991). https://doi.org/10.1093/nar/19.24.6793
Article CAS PubMed PubMed Central Google Scholar
M.F. Rosa, V. Ivana, D.M. Giancarlo, T. Dario, P. Sabrina, B. Andrea, C. Pierlorenzo, P. Claudio, A.R. Marina, M. Kristian, H. Carlo, M. Croce, A. Fusco, HMGA2 induces pituitary tumorigenesis by enhancing E2F1 activity. Cancer Cell 9(6), 459–471 (2006). https://doi.org/10.1016/j.ccr.2006.04.024
X. Wang, X. Liu, A.Y.-J. Li, L. Chen, L. Lai, H.H. Lin, S. Hu, L. Yao, J. Peng, S. Loera, L. Xue, B. Zhou, L. Zhou, S. Zheng, P. Chu, S. Zhang, D.K. Ann, Y. Yen, Overexpression of HMGA2 promotes metastasis and impacts survival of colorectal cancers. Clin. Cancer Res. 17(8), 2570–2580 (2011). https://doi.org/10.1158/1078-0432.CCR-10-2542
A. Morishita, M.R. Zaidi, A. Mitoro, D. Sankarasharma, M. Szabolcs, Y. Okada, J. D'Armiento, K. Chada, HMGA2 is a driver of tumor metastasis. Cancer Res. 73(14), 4289–4299 (2013). https://doi.org/10.1158/0008-5472.CAN-12-3848
J. Wu, Z. Liu, C. Shao, Y. Gong, E. Hernando, P. Lee, M. Narita, W. Muller, J. Liu, J.-J. Wei, Cancer Res 71(2), 349–359 (2011). https://doi.org/10.1158/0008-5472.CAN-10-2550
Article CAS PubMed PubMed Central Google Scholar
R. Cao, Z. Meng, T. Liu, G. Wang, G. Qian, T. Cao, X. Guan, H. Dan, Y. Xiao, X. Wang, Oncotarget 7(45), 72941–72960 (2016). https://doi.org/10.18632/oncotarget.12146
Article PubMed PubMed Central Google Scholar
W.M. Ongkeko, D. Burton, A. Kiang, E. Abhold, S.Z. Kuo, E. Rahimy, M. Yang, R.M. Hoffman, J. Wang-Rodriguez, L.J. Deftos, S. Singh, Parathyroid hormone related-protein promotes epithelial-to- mesenchymal transition in prostate cancer. PLoS One 9(1), e85803 (2014). https://doi.org/10.1371/journal.pone.0085803
Y. Li, Z. Zhao, C. Xu, Z. Zhou, Z. Zhu, T. You, HMGA2 induces transcription factor slug expression to promote epithelial-to-mesenchymal transition and contributes to colon cancer progression. Cancer Lett. 355(1), 130–140 (2014). https://doi.org/10.1016/j.canlet.2014.09.007
留言 (0)